ALZAMEND NEURO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.718 USD | +0.98% |
|
+1.24% | -19.33% |
Chart calendar Alzamend Neuro, Inc.
b8935ca98290.K6BXoOELxg7NrTT1vB3O4hhN0ScYgm1fxBhma7pvrBg.RucEkoBtr2ej-GDF60qGsF8MokF39ggb93sOPtMp3X5O7xWTu2iePJ_lVw~3871173b4125b27110f7188e7276e1ea
Upcoming events on Alzamend Neuro, Inc.
No events available
Past events on Alzamend Neuro, Inc.
| 30/04/2024 09:30 pm | Annual General Meeting |
| 29/09/2023 09:30 pm | Extraordinary Shareholders Meeting |
| 16/03/2023 05:30 pm | Q3 2023 Earnings Release |
| 02/02/2023 09:00 pm | Sequire Biotechnology Conference |
| 07/06/2022 | LD Micro Conference |
| 15/03/2022 | Q3 2022 Earnings Release |
| 07/06/2021 | Investor Meeting |
Annual results
| Fiscal Period | April | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -7,91 -7,87 -0.54% | -11,3 -12,4 9.16% | -10,7 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -12,3 -11,6 -6.46% | -14,9 -15,9 6.48% | -11,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -12,4 -12,2 -1.39% | -14,9 -15,9 6.46% | -11,8 |
|
Net income Million USD | Released Forecast Spread | -5,05 | -12,4 -11,6 -6.41% | -14,9 -15,9 6.46% | -11,8 |
|
EPS USD | Released Forecast Spread | -1,05 | -2,10 -1,88 -12% | -2,25 -2,40 6.25% | -1,73 |
| Announcement Date | 29/07/21 | 19/07/22 | 27/07/23 | - |
Quarterly results
| Fiscal Period | April | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -1,43 -2,42 41.08% | -2,62 -2,57 -1.79% | -2,39 -3,03 21.17% | -3,91 -3,30 -18.48% | -2,81 -4,00 29.79% | -3,51 -3,50 -0.38% | -2,57 -4,60 44.12% | -2,46 -2,60 5.36% | -2,50 | -3,80 | -3,80 | -3,80 | -3,80 | |
|
EBIT Million USD | Released Forecast Spread | -2,56 -2,80 8.79% | -3,87 -3,12 -23.95% | -3,04 -6,06 49.92% | -3,11 -3,90 20.35% | -5,42 -4,00 -35.59% | -3,31 -4,32 23.47% | -3,53 -4,00 11.85% | -2,90 -4,41 34.21% | -2,66 -2,72 2.35% | -2,70 | -4,00 | -4,00 | -4,00 | -4,00 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,57 -3,70 30.46% | -3,87 -3,70 -4.58% | -3,11 -3,90 20.26% | -5,43 -4,00 -35.64% | -3,31 -4,32 23.46% | -3,53 -4,00 11.81% | -2,91 -4,41 34.11% | -2,66 -2,72 2.26% | -2,70 | -4,00 | -4,00 | -4,00 | -4,00 | |
|
Net income Million USD | Released Forecast Spread | -2,57 -2,80 8.21% | -3,87 -3,12 -23.84% | -3,04 -6,06 49.89% | -3,11 -3,90 20.26% | -5,43 -4,00 -35.64% | -3,31 -4,32 23.46% | -3,53 -4,00 11.81% | -2,91 -4,41 34.11% | -2,66 -2,72 2.26% | -2,70 | -4,00 | -4,00 | -4,00 | -4,00 |
|
EPS USD | Released Forecast Spread | -0,45 -0,45 0% | -0,75 -0,53 -42.86% | -0,45 -1,05 57.14% | -0,45 -0,60 25% | -0,90 -0,60 -50% | -0,45 -0,68 33.33% | -0,60 -0,60 0% | -0,44 -0,68 34.81% | -0,38 -0,33 -16.92% | -0,38 | -0,55 | -0,54 | -0,54 | -0,53 |
| Announcement Date | 15/03/22 | 19/07/22 | 13/09/22 | 12/12/22 | 15/03/23 | 27/07/23 | 13/09/23 | 15/12/23 | 25/03/24 | - | - | - | - | - |
| Today 04:00 pm | MODERNA, INC.: Q1 2024 Earnings Release |
| Today 04:30 pm | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| Today 04:30 pm | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| Today 04:30 pm | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| Today 05:30 pm | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 06/05/2024 | REVOLUTION MEDICINES, INC.: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | SYNDAX PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
| 07/05/2024 | VERVE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | OLEMA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Alzamend Neuro, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALZN Stock
- Calendar Alzamend Neuro, Inc.
